WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

No Result

View All Result

No Result

View All Result

No Result

View All Result

Home Author

Admin

WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

byAdmin

July 27, 2021

First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualification to...

New Local Partnership Sees uCloudlink’s PaaS and SaaS Ecosystem Expansion in Southeast Asia

byAdmin

July 28, 2021

HONG KONG, July 26, 2021 /PRNewswire/ -- UCLOUDLINK GROUP INC. (NASDAQ: UCL, "uCloudlink"), the world's first and leading mobile data...

Investor Relationship platform Jihuibao: Fujian Supertech Advanced Material signs deal to build a vacuum insulation material manufacturing facility in Hefei, Anhui province

byAdmin

July 27, 2021

SHENZHEN, China, July 26, 2021 /PRNewswire/ -- Jihuibao, an investor relationship platform, issued the following article about Fujian Supertech Advanced...